Who are SAB Biotherapeutics, Inc.'s major customers?

SAB Biotherapeutics, Inc. (SABSW) key customers include: Biodexa Pharmaceuticals Plc. View the full customer network at chainsifter.com/chain/SABSW.

What sector is SAB Biotherapeutics, Inc. in?

SAB Biotherapeutics, Inc. (SABSW) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

SABSW Supply Chain: SAB Biotherapeutics, Inc. Suppliers & Customers

0Suppliers

1Customers

1Debt Items

11Related Chains

SAB Biotherapeutics, Inc. Suppliers

No suppliers on recordSAB Biotherapeutics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

SAB Biotherapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
BDRX	Biodexa Pharmaceuticals Plc	72%	Reciprocal relationship from BDRX graph: ll therapies by Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics AG and SAB Biotherapeutics, Inc. is developing an immunotherapeutic. The JDRF T1D Fund ha…

SAB Biotherapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
SABSW-DEBT-12350	Warrants outstanding: 0.01	90%	xbrl warrant detail from xbrl 2024-12-31.

SAB Biotherapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for SAB Biotherapeutics, Inc..

SAB Biotherapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for SAB Biotherapeutics, Inc..

SAB Biotherapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
BDRX	Biodexa Pharmaceuticals Plc	100.00	1	['customer']
RXRX	Recursion Pharmaceuticals, Inc.	50.00	2
TARA	Protara Therapeutics, Inc.	50.00	2
CNSP	CNS Pharmaceuticals, Inc.	50.00	2
CGON	CG Oncology, Inc.	50.00	2
CRSP	CRISPR Therapeutics AG	50.00	2
COGT	Cogent Biosciences, Inc.	50.00	2
GSK	GSK plc	50.00	2
TPST	Tempest Therapeutics, Inc.	50.00	2
PSTV	Plus Therapeutics, Inc.	50.00	2
SABS	SAB Biotherapeutics, Inc.	50.00	2

SAB Biotherapeutics, Inc. Supply Chain